Predicting P-Glycoprotein Effects on Oral Absorption: Correlation of Transport in Caco-2 with Drug Pharmacokinetics in Wild-Type and mdr1a(-/-) Mice in Vivo

By Collett Andrew   Tanianis-Hughes Jolanta   Hallifax David   Warhurst Geoff  

Pharmaceutical Research, Vol. 21, Iss. 5, 2004-05 ,pp. : 819-826

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs

By Sakaeda Toshiyuki   Nakamura Tsutomu   Okumura Katsuhiko  

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 397-410

Future Medicine

Access to resources Recommend Favorite

MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin

By Roulet A.   Puel O.   Gesta S.   Lepage J.-F.   Drag M.   Soll M.   Alvinerie M.   Pineau T.  

European Journal of Pharmacology, Vol. 460, Iss. 2, 2003-01 ,pp. : 85-91

Elsevier

Access to resources Recommend Favorite

Characterisation of cerivastatin as a P-glycoprotein substrate: studies in P-glycoprotein-expressing cell monolayers and mdr1a/b knock-out mice

By Kivistö Kari   Zukunft Jörg   Hofmann Ute   Niemi Mikko   Rekersbrink Sabine   Schneider Swetlana   Luippold Gerd   Schwab Matthias   Eichelbaum Michel   Fromm Martin  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 2, 2004-08 ,pp. : 124-130

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-Glycoprotein

By  

Current Drug Metabolism, Vol. 3, Iss. 3, 2002-06 ,pp. : 257-273

Bentham Science Publishers

Access to resources Recommend Favorite